VA2914

· HRA Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VA2914, covering 2010-06-17 to 2010-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914 [Phase 2]